Abstract
Thymus pathology embraces a broad spectrum of features, varying from major immunologic abnormalities affecting all organ systems to minor abnormalities with limited clinical consequences. Some individuals with thymus pathology may have all the features of the disease while others may have only a few features. In this chapter we will review clinical features of common thymus pathologies. Tables 7.1 and 7.2 list the localized and systemic symptoms due to mediastinal tumors [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Crapo JD, Glassroth J, Karlinsky J et al (2004) Baum’s textbook of pulmonary diseases. Lippincott Williams & Wilkins, Philadelphia, PA
Assarsson E, Chambers BJ, Hogstrand K et al (2007) Severe defect in thymic development in an insertional mutant mouse model. J Immunol 178:5018–5027
Boehm T, Bleul CC (2007) The evolutionary history of lymphoid organs. Nat Immunol 8:131–135
Devriendt K, Fryns JP, Mortier G et al (1998) The annual incidence of DiGeorge/velocardiofacial syndrome. J Med Genet 35:789–90
Sullivan KE, Jawad AF, Randall P et al (1998) Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 86:141–146
Kobrynski LJ, Sullivan KE (2007) Velocardiofacial syndrome, DiGeorge syndrome: The chromosome 22q11.2 deletion syndromes. Lancet 370:1443–1452
McLean-Tooke G, Spickett P, Gennery AR (2007) Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 66:1–7
McDonald-McGinn DM, Kirschner R, Goldmuntz E et al (1999) The Philadelphia story: The 22q11.2 deletion: Report on 250 patients. Genet Couns 10:11–24
Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: A European collaborative study. J Med Genet 34:798–804
Gerdes M, Solot C, Wang PP et al (1999) Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Gene 85:127–133
Moss EM, Batshaw ML, Solot CB et al (1999) Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J Pediatr 134:193–198
Swillen A, Devriendt K, Legius E et al (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: A study of 37 children and adolescents with VCFS. J Med Gene 34: 453–458
Wang PP, Woodin MF, Kreps-Falk R et al (2000) Research on behavioral phenotypes: Velocardiofacial syndrome (deletion 22q11.2). Dev Med Child Neurol 42: 422–427
Weller E, Weller R, Jawad A et al (1999) Psychiatric diagnoses in children with velocardiofacial syndrome, American Academy of Child and Adolescent Psychiatry, Chicago
Vantrappen G, Devriendt K, Swillen A et al (1999) Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience, Genet Coun 10:3–9
Yan W, Jacobsen LK, Krasnewich DM et al (1998) Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired”. Am J Med Genet 81:41–4
Motzkin B, Marion R, Goldberg R et al (1993) Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 123:406–410
Shprintzen RJ, Goldberg R, Golding-Kushner KJ et al (1992) Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 42:141–142
Lischner HW, Dacou C, DiGeorge AM (1967) Normal lymphocyte transfer (NLT) test: Negative response in a patient with congenital absence of the thymus. Transplantation 5:555
Botto LD, May K, Fernhoff PM, Correa A et al (2003) A population-based study of the 22q11.2 deletion: Phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107
McDonald-McGinn DM, LaRossa D et al (1997) The 22q11.2 deletion: Screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test 1:99–108
Goldmuntz E (2005) DiGeorge Syndrome: New Insights. Clinics in Perinatology 32:963–978
Wurdak H, Ittner LM, Sommer L (2007) DiGeorge syndrome and pharyngeal apparatus development. Bioessays 28:1078–1086
Eicher PS, McDonald-McGinn DM, Fox CA et al (2000) Dysphagia in children with a 22q11.2 deletion: Unusual pattern found on modified barium swallow. J Pediatr 137:158–164
Dyce O, McDonald-McGinn D, Kirschner RE et al (2002) Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch Otolaryngol Head Neck Surg 128:1408–1412
Brauner R, Le Harivel de Gonneville A, Kindermans C et al (2003) Parathyroid function and growth in 22q11.2 deletion syndrome. J Pediatr 142:504–508
Taylor SC, Morris G, Wilson D et al (2003) Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child 88:520–522
Scire G, Dallapiccola B, Iannetti P et al (1994) Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. Am J Med Genet 52:478–482
Greig F, Paul E, DiMartino-Nardi J et al (1996) Transient congenital hypoparathyroidism: Resolution and recurrence in chromosome 22q11 deletion. J Pediatr 128:563–567
Jawad AF, McDonald-McGinn DM, Zackai E et al (2001) Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 139:715–723
Sullivan KE (2004) The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol 4:505–512
DiGeorge AM (1968) Congenital absence of the thymus and its immunological consequences: Concurrance with congenital hypothyroidism. Birth Defects 4:116–121
Barrett DJ, Ammann AJ, Wara DW et al (1981) Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 6:1–6
Bastian J, Law S, Vogler L et al (1989) Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 115:391–396
Chinen J, Rosenblatt HM, Smith EO et al (2003) Longterm assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 111:573
Sullivan KE, McDonald-McGinn D, Driscoll DA et al (1999) Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 6:906
Gennery AR, Barge D, O’Sullivan JJ et al (2002) Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 86:422
Smith CA, Driscoll DA, Emanuel BS et al (1998) Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 5:415
Davies K, Stiehm ER, Woo P, Murray KJ (2001) Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol 28:2326–2334
Davies JK, Telfer P, Cavenagh JD et al (2003) Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol 25:195–197
Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan KE (2003) Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr 143:277–278
Kratz CP, Niehues T, Lyding S et al (2003) Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: A case report. Pediatr Hematol Oncol 20:167–172
Digilio MC, Giannotti A, Castro M et al (2003) Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo-cardio-facial syndrome). Am J Med Genet 121A:286–288
Scattone A, Caruso G, Marzullo A et al (2003) Neoplastic disease and deletion 22q11.2: A multicentric study and report of two cases. Pediatr Pathol Mol Med 22:323–341
McDonald-McGinn DM, Reilly A, Wallgren-Pettersson C et al (2006) Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet A 140:906
Simon TJ, Bearden CE, Moss EM et al (2002) Cognitive development in VCFS. Prog Pediatr Cardiol 15:109–117
Fine SE, Weissman A, Gerdes M et al (2005) Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome. J Autism Dev Disord 35:70
Shprintzen RJ, Goldberg RB, Lewin ML et al (1978) A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: Velo-cardio-facial syndrome. Cleft Palate J 15:56
Dadmanesh F, Sekihara T, Rosai J (2001) Histologic typing of thymoma according to the new World Health Organization classification. Chest Surg Clin N Am 11:407–420
Ito M, Taki T, Miyake M et al (1988) Lymphocyte subsets in human thymoma studied with monoclonal antibodies. Cancer 61:284–287
Chan WC, Zaatari GS, Tabei S et al (1984) Thymoma: An immunohistochemical study. Am J Clin Pathol 82:160–166
Bernatz PE, Harrison EG, Clagett OT (1961) Thymoma: A clinicopathologic study. Thorac Cardiovasc Surg 42:424–444
Gray GF, Gutowsk III WT (1979) Thymoma. A clinicopathologic study of 54 cases. Am J Surg Pathol 3:235–249
Pescarmona E, Rendina EA, Venuta F et al (1990) The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases Am J Clin Pathol 93:190–195
Lattes R, Jonas S (1957) Pathological and clinical features in 80 cases of thymoma. Bull N Y Acad Med 33:145–147
Marino M, Muller-Hermelink HK (1985) Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 407:119–149
Kirchner T, Muller-Hermelink HK (1989) New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol 10:167–189
Quintanilla-Martinez L, Wilkins EW Jr, Choi N, Efird J et al (1994) Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 74:606–617
Rosai J, Sobin LH (1999) Histological typing of tumours of the thymus. WHO, International histologic classification of tumors. Springer-Verlag, Berlin
Chalabreysse L, Roy P, Cordier JF et al (2002) Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: A retrospective study of 90 tumors. Am J Surg Pathol 26:1605–1611
Ströbel P, Marx A, Zettl A, (2005) Thymoma and thymic carcinoma: An update of the WHO Classification 2004. Surg Today 35:805–811
Suster S, Moran CA (2006) Thymoma classification: Current status and future trends. Am J Clin Pathol 125:542–554
Kuo T (2000) Cytokeratin profiles of the thymus and thymomas: Histogenetic correlations and proposal for a histological classification of thymomas. Histopathology 36:403
Masaoka A, Monden Y, Nakahara K et al (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492
Okumura MD, Ohta M, Tateyama H (2002) A clinical study of 273 patients. Cancer 94:624–632
Sonobi S, Miyamoto H, Ozumi H (2005) Clinical usefulness of the WHO histological classification of thymoma. Ann of Thorac Cardiovasc Surg 11:367–373
Kondo K, Yoshizawa K et al (2004) WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg 77:1183–1188
Kim DJ, Yang WI, Choi SS et al (2005) Prognostic and clinical relevance of the World Health Organization schema for the classification of thymic epithelial tumors: A clinicopathologic study of 108 patients and literature review. Chest 127:755–761
Rena O, Papalia E, Maggi G et al (2005) World Health Organization histologic classification: An independent prognostic factor in resected thymomas. Lung Cancer 50:59–66
Chen G, Marx A, Wen-Hu C (2002) New WHO histologic classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer 95:420–429
Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: State of the art. J Clin Oncol 17:2280–2289
Patterson GA (1992) Thymomas. Semin Thorac Cardiovasc Surg 4:39–44
Engels EA, Pfeiffer RM (2003) Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546–551
Spigland N, Di Lorenzo M, Youssef S et al (1990) Malignant thymoma in children: A 20-year review. J Pediatr Surg 25:1143–1146
Cohen DJ, Ronnigen LD, Graeber GM et al (1984) Management of patients with malignant thymoma. J Thorac Cardiovasc Surg 87:301
Sperling B, Marschall J, Kennedy R (2003) Thymoma: A review of the clinical and pathological findings in 65 cases Can J Surg 46:37–42
Morgenthaler TI, Brown LR, Colby TV et al (1993) Thymoma. Mayo Clin Proc 68:1110–1123
Moran CA, Travis WD, Rosado-de-Christenson M et al (1992) Thymomas presenting as pleural tumors. Report of eight cases. Am J Surg Pathol 16:138
Nishimura T, Kondo M, Miyazaki S et al (1982) Two-dimensional echocardiographic findings in cardiovascular involvement by invasive thymoma. Chest 81:752–754
McAllister HA, Fenoglio JJ (1978) Atlas of tumor pathology. Tumors of the cardiovascular system. Second series, fascicle 15. Armed Forces Institute of Pathology, Washington DC
Blumberg D, Burt ME, Bains MS et al (1998) Thymic carcinoma: Current staging does not predict prognosis. J Thorac Cardiovasc Surg 115:303–9
Abiko M, Sato T, Shiono S et al (1999) A case of invasive thymoma displaying endobronchial extension. J Jpn Soci Bronch 21:289–293
Sakuraba M, Sagara Y, Tamura A (2005) A case of invasive thymoma with endobronchial growth. Ann Thorac Cardiovasc Surg 11(2):114–116
Wright C, Wain C (2006) Acute presentation of thymoma with infarction or hemorrhage. Ann Thorac Surg 82:1901–1904
Jung JI, Kim HH, Park SH (1999) Malignant ectopic thymoma in the neck: A case report. Am J Neuroradiol 20:1747–1749
Silverman NA, Sabiston DC Jr (1980) Mediastinal masses. Surg Clin North Am 60:757–777
Lennon VA, Lambert EH (1980) Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285:238–240
Souadjian JV, Enriquez P, Silverstein MN et al (1974) The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med 134:374–379
Shields TW (1991) Thymic tumors. In: Shields TW (ed) Mediastinal surgery. Lea & Febiger, Philadelphia
Hayashi A, Shiono H, Okumura M (2007) Thymoma accompanied by lichen planus. Interact Cardiovasc Thorac Surg
Bailey RO, Dunn HG, Rubin AM et al (1988) Myasthenia gravis with thymoma and pure red blood cell aplasia. Am J Clin Pathol 89:687–693
Krantz SB (1990) Pure red cell aplasia. In: Givel JC, Merlini M, Clarke DB, Dusmet M (eds) Surgery of the thymus. Pathology, associated disorders and surgical technique. Springer-Verlag, Berlin
Palmieri G, Lastoria S, Colao A et al (1997) Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 336:263
Good RA (1954) Agammaglobulinemia: A provocative experiment of nature. Bull Univ Minn Hosp 26:1
Rosenberg JC (1993) Neoplasms of the mediastinum. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, 4th edn. JB Lippincott, Philadelphia
Rosado de Christenson ML, Galobardes J, Moran CA (1992) Thymoma: Radiologic-pathologic correlation. Radiographics 12:151–168
Kiyosue H, Miyake H, Komatsu E, Mori H (1994) MRI of cervical masses of thymic origin. J Comput Assist Tomogr 18:206–208
Sakai F, Sone S, Kiyono K et al (1992) MR imaging of thymoma: Radiologic-pathologic correlation. AJR Am J Roentgenol 158:751–756
Lastoria S, Vergara E, Palmieri G et al (1998) In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phel-octreotide scintigraphy. J Nucl Med 39:634–639
Liu RS, Yeh SH, Huang MH et al (1995) Use of fluorine—18 fluorodeoxyglucose positron emission tomography in the detection of Thymoma: A preliminary report. Eur J Nucl Med 22:1402–1407
Lewis JE, Wick MR, Scheithauer BW et al (1987) Thymoma: A clinicopathologic review. Cancer 60:2727–2743
Blumberg D, Port JL, Weksler B et al (1995) Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg 60:908–913
Kohman LJ (1997) Controversies in the management of malignant thymoma. Chest 112:296S–300S
Gripp S, Hilgers K, Wurm R (1998) Thymoma: Prognostic factors and treatment outcomes. Cancer 83:1495–1503
Kurup A, Loehrer PJ Sr (2004) Thymoma and thymic carcinoma: Therapeutic approaches. Clin Lung Cancer 6:28–32
Curran WJ Jr, Kornstein MJ, Brooks JJ, Turrisi AT 3rd (1988) Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6:1722–1727
Hsu CP, Chen CY, Chen CL et al (1994) Thymic carcinoma: Ten years’ experience in twenty patients. J Thorac Cardiovasc Surg 107:615–620
Walker AN, Mills SE, Fechner RE (1990) Thymomas and thymic carcinomas. Semin Diagn Pathol 7:250–265
Ritter JH, Wick MR (1999) Primary carcinomas of the thymus gland. Semin Diagn Pathol 16:18–31
Chung DA (2000) Thymic carcinoma — Analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg 48:114–119
Hishima T, Fukayama M, Fujisawa M et al (1994) CD5 expression in thymic carcinoma. Am J Pathol 145:268–275
Suster S, Rosai J (1991) Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer 67:1025–1032
Wick MR, Scheithauer BW, Weiland LH et al (1982) Primary thymic carcinomas. Am J Surg Pathol 6:613–630
Leyvraz S, Henle W, Chahinian AP et al (1985) Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 312:1296–1299
Lee JD, Choe KO, Kim SJ et al (1991) CT findings in primary thymic carcinoma. J Comput Assist Tomogr 15:429–433
Thomas CR, Wright CD, Loehrer PJ (1999) Thymoma: State of the art. J Clin Oncol 17:2280–2289
Wick MR, Rosai J (1990) Neuroendocrine, germ cell, and nonepithelial tumors. In: Givel JC, Merlini M, Clarke DB, Dusmet M (eds) Surgery of the thymus. Pathology, associated disorders and surgical technique. Springer-Verlag, Berlin
Burns DE, Schiffman FJ (1993) Beguiled by the gallium: Thymic rebound in an adult after chemotherapy for Hodgkin’s disease. Chest 104:1916–1919
Rios A, Torres J, Roca MJ (2006) Primary thymic lymphomas. Rev Clin Esp 206:326–331
Inagaki H, Chan JK, Ng JW et al (2002) Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J of Path 160:1435–1443
Shimizu K, Ishii G, Nagai K et al (2005) Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue (MALT Lymphoma) in the Thymus: Report of Four Cases. Japanese Journal of Clinical Oncology 35:412–416
Tiffet O, Nicholson AG, Ladas G et al (2003) A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 124:141–146
Wick MR, Scott RE, Li CY et al (1980) Carcinoid tumor of the thymus: A clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc 55:246–254
Fukai I, Masaoka A, Fujii Y et al (1999) Thymic neuroendocrine tumor (thymic carcinoid): A clinicopathologic study in 15 patients. Ann Thorac Surg 67:208–211
De Montpreville VT, Macchiarini P, Dulmet E (1996) Thymic neuroendocrine carcinoma (carcinoid): A clinicopathologic study of fourteen cases. J Thorac Cardiovasc Surg 111:134–141
Economopoulos G, Lewis J Jr, Lee M et al (1990) Carcinoid tumors of the thymus. Ann Thorac Surg 50:58–61
Yamakawa Y, Masaoka A, Hashimoto T et al (1991) A tentative tumor-node-metastasis classification of thymoma. Cancer 68:1984–1987
Gelfand E, Basualdo C, Callaghan J (1981) Carcinoid tumor of the thymus associated with recurrent pericarditis. Chest 79:350–351
Wick MR, Rosai J (1991) Neuroendocrine neoplasms of the mediastinum. Semin Diagn Pathol 8:35–51
Moran CA, Suster S, Fishback N, Koss MN (1993) Mediastinal paragangliomas: A clinicopathologic and immunohistochemical study of 16 cases. Cancer 72:2358–2364
Pneumocystis pneumonia — Los Angeles, 1981 (1996) MMWR Morb Mortal Wkly Rep 30:250–252
Barre-Sinoussi F, Chermann JC, Rey F et al (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
Joshi VV (1991) Pathologic changes associated with HIV infection in children. In: Pizzo PA, Wilfred CM (eds) Pediatric AIDS. Williams & Wilkins, Baltimore
Leonidas J, Berdon W, Valderrama E et al (1996) Human immunodeficiency virus infection and multilocular thymic cysts. Radiology 198:377–379
Avila N, Mueller B, Carrasquillo J et al (1996) Multilocular thymic cysts: Imaging features in children with human immunodeficiency virus infection. Radiology 201:130–134
Haynes BF, Hale LP, Weinhold KJ et al (1999) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103:453–460
Haynes BF, Hale LP (1998) The human thymus: A chimeric organ comprised of central and peripheral lymphoid components. Immunol Res 3:175–92
Haynes BF, Hale LP, Weinhold KJ et al (1999) Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 103:921
Sopper S, Nierwetberg D, Halbach A et al (2003) Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood 101:1213–1219
Autran B, Carcelain G, Li TS et al (1997) Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112–116
Zhang ZQ, Notermans DW, Sedgewick G et al (1998) Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A 95:1154–1159
Duprez A, Cordier R, Schmitz P (1962) Tuberculoma of the thymus. First case of surgical excision. J Urol Nephrol 44:115–120
Simmers TA, Jie C, Sie MC (1997) Thymic tuberculosis: A case report. Neth J Med 51:87–90
FitzGerald JM, Mayo JR, Miller RR et al (1992) Tuberculosis of the thymus. Chest 102:1604–1605
Nobrega C, Cardona PJ, Roque S et al (2007) The thymus as a target for mycobacterial infections. Microbes Infect 9:1521–1529
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Italia
About this chapter
Cite this chapter
Khaleeq, G., Ali, H.A., Musani, A.I. (2008). Clinical Features of Thymus Pathology. In: Lavini, C., Moran, C.A., Morandi, U., Schoenhuber, R. (eds) Thymus Gland Pathology. Springer, Milano. https://doi.org/10.1007/978-88-470-0828-1_7
Download citation
DOI: https://doi.org/10.1007/978-88-470-0828-1_7
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0827-4
Online ISBN: 978-88-470-0828-1
eBook Packages: MedicineMedicine (R0)